Buckingham Capital Management, Inc. Abb Vie Inc. Transaction History

Buckingham Capital Management, Inc.

$863 Million
Q3 2024

A detailed history of Buckingham Capital Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Buckingham Capital Management, Inc. holds 3,226 shares of ABBV stock, worth $580,680. This represents 0.07% of its overall portfolio holdings.

Number of Shares

3,226

Previous 3,224 0.06%

Holding current value

$580,680

Previous $552,000 15.4%

% of portfolio

0.07%

Previous 0.07%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$163.84 - $199.33 $327 - $398	2 Added 0.06%	3,226 $637,000
Q2 2024 Jul 15, 2024	BUY	$154.79 - $180.76 $310,044 - $362,062	2,003 Added 164.05%	3,224 $552,000
Q1 2024 Apr 10, 2024	SELL	$159.82 - $182.1 $15,023 - $17,117	-94 Reduced 7.15%	1,221 $222,000
Q4 2023 Feb 07, 2024	BUY	$137.6 - $154.97 $180,944 - $203,785	1,315 New	1,315 $203,000
Q1 2023 Apr 11, 2023	BUY	$144.61 - $166.54 $578 - $666	4 Added 0.28%	1,456 $232,000
Q4 2022 Jan 24, 2023	BUY	$138.31 - $165.87 $200,826 - $240,843	1,452 New	1,452 $0
Q2 2022 Aug 05, 2022	SELL	$137.62 - $174.96 $188,401 - $239,520	-1,369 Closed	0 $0
Q1 2022 May 06, 2022	SELL	$131.98 - $163.75 $59,918 - $74,342	-454 Reduced 24.9%	1,369 $222,000
Q4 2021 Feb 07, 2022	BUY	$107.43 - $135.93 $195,844 - $247,800	1,823 New	1,823 $247,000
Q3 2021 Nov 08, 2021	SELL	$106.4 - $120.78 $191,413 - $217,283	-1,799 Closed	0 $0
Q2 2021 Jul 27, 2021	BUY	$105.21 - $117.21 $189,272 - $210,860	1,799 New	1,799 $203,000
Q1 2021 May 04, 2021	SELL	$102.3 - $112.62 $204,190 - $224,789	-1,996 Closed	0 $0
Q4 2020 Feb 04, 2021	BUY	$80.49 - $108.67 $160,658 - $216,905	1,996 New	1,996 $214,000
Q1 2020 May 06, 2020	SELL	$64.5 - $97.79 $146,608 - $222,276	-2,273 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$72.13 - $90.25 $163,951 - $205,138	2,273 New	2,273 $201,000
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $914,343 - $1.1 Million	-14,518 Closed	0 $0
Q2 2019 Aug 09, 2019	SELL	$65.7 - $83.98 $1.72 Million - $2.19 Million	-26,112 Reduced 64.27%	14,518 $1.06 Million
Q1 2019 May 07, 2019	SELL	$77.14 - $90.79 $519,383 - $611,289	-6,733 Reduced 14.22%	40,630 $3.27 Million
Q4 2018 Feb 04, 2019	SELL	$77.85 - $96.01 $196,804 - $242,713	-2,528 Reduced 5.07%	47,363 $4.37 Million
Q3 2018 Nov 20, 2018	SELL	$88.91 - $98.84 $13,158 - $14,628	-148 Reduced 0.3%	49,891 $4.72 Million
Q2 2018 Aug 10, 2018	BUY	$89.78 - $106.23 $900,672 - $1.07 Million	10,032 Added 25.08%	50,039 $4.64 Million
Q1 2018 May 11, 2018	SELL	$92.01 - $123.21 $68,915 - $92,284	-749 Reduced 1.84%	40,007 $3.79 Million
Q4 2017 Feb 13, 2018	SELL	$89.56 - $98.21 $264,381 - $289,915	-2,952 Reduced 6.75%	40,756 $3.94 Million
Q3 2017 Nov 07, 2017	SELL	$69.85 - $89.22 $357,422 - $456,538	-5,117 Reduced 10.48%	43,708 $3.88 Million
Q2 2017 Aug 10, 2017	BUY	N/A	48,825	48,825 $3.54 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Buckingham Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Buckingham Capital Management, Inc. with notifications on news.

Account

Buckingham Capital Management, Inc. Abb Vie Inc. Transaction History